Overview

An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This was an open label, randomized, single dose, three period crossover pharmacokinetic study of Chronocort® in 30 healthy male volunteers. The study was conducted in smaller sub groups (Group 1, n=18 and Group 2, n=12).
Phase:
Phase 1
Details
Lead Sponsor:
Diurnal Limited
Collaborator:
Simbec Research
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate